- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01984385
Hip Fracture Impact on Vascular Events In Noncardiac Surgery patIents: a cOhort evaluatioN (Hip VISION): Pilot Study
October 5, 2015 updated by: P.J. Devereaux, Population Health Research Institute
Hip VISION (Pilot Study) is a Prospective Observational Cohort Study to evaluate the incidence of overall and cause-specific mortality among consecutive patients aged ≥ 18 years presenting with hip fracture to the Juravinski Hospital of the Hamilton Health Sciences.
This pilot study will assess the feasibility of a larger prospective international cohort study.
After eligibility has been confirmed and informed consent has been obtained, participants will be registered in the study.
Troponin level, complete blood counts and serum creatinine level will be collected at day 1 through day 10 post admission.
CAM instrument will be employed at admission and once daily post admission day 1 through day 10.
FIM Instrument will be administered within 72 hours of admission to establish pre-fracture functional independence and disability.
Patients will be contacted by research personnel by telephone 30 days after study registration.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Hamilton, Ontario, Canada, L8V 5C2
- Juravinski Hospital and Cancer Centre (HHS)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with hip fracture
Description
Inclusion Criteria:
- Patients aged ≥ 18 years with hip fractures (i.e. fractures involving the subcapital, femoral neck, or intertrochanteric regions), treated either operatively or non-operatively
Mechanism of injury consistent with either:
- A fall from a standing height or;
- Another mechanism of injury which, in the clinical judgment of an orthopedic surgeon, would impart the same or less traumatic energy as a fall from a standing height
Exclusion Criteria:
- Patients with fractures isolated to the proximal femoral shaft, with no involvement of the intertrochanteric, femoral neck, or subcapital region
- Patients with hip fractures resulting from high energy mechanisms, such as motor vehicle accidents or falls from a substantial height
- Patient who refuse 30-day or 6-month follow up
- Patients who refuse to consent either by themselves or through a substitute decision-maker (for patients unable to consent, we will use a deferred consent process, as described below).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Patients with a hip fracture
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total and cause specific mortality in hip fracture patients at 30 days
Time Frame: 30 days
|
30 days
|
|
|
Major complications within 30 days.
Time Frame: 30 days
|
Composite of vascular mortality, nonfatal MI, nonfatal stroke, nonfatal PE, sepsis, and life-threatening bleeding.
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Length of hospital stay
Time Frame: 30 days
|
30 days
|
|
Nonfatal myocardial infarction
Time Frame: 30 days
|
30 days
|
|
Nonfatal myocardial injury after noncardiac surgery
Time Frame: 30 days
|
30 days
|
|
Nonfatal pulmonary embolism
Time Frame: 30 days
|
30 days
|
|
Nonfatal infection
Time Frame: 30 days
|
30 days
|
|
Nonfatal bleeding
Time Frame: 30 days
|
30 days
|
|
Nonfatal stroke
Time Frame: 30 days
|
30 days
|
|
New congestive heart failure
Time Frame: 30 days
|
30 days
|
|
New atrial fibrillation
Time Frame: 30 days
|
30 days
|
|
Nonfatal cardiac arrest
Time Frame: 30 days
|
30 days
|
|
Deep vein thrombosis
Time Frame: 30 days
|
30 days
|
|
New acute renal failure requiring dialysis
Time Frame: 30 days
|
30 days
|
|
Cardiac catheterization
Time Frame: 30 days
|
30 days
|
|
PCI
Time Frame: 30 days
|
30 days
|
|
CABG
Time Frame: 30 days
|
30 days
|
|
CAM days 1-7 post-op
Time Frame: 1-7 days post-op
|
1-7 days post-op
|
|
Implant failure or periprosthetic fracture
Time Frame: 30 days
|
30 days
|
|
Re-operation
Time Frame: 30 days
|
30 days
|
|
New nursing home residence
Time Frame: 30 days
|
30 days
|
|
First mobilization
Time Frame: 30 days
|
30 days
|
|
FIM (motor function)
Time Frame: 30 days
|
30 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: PJ Devereaux, PhD, Population Health Research Institute
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2013
Primary Completion (Actual)
September 1, 2014
Study Completion (Actual)
October 1, 2015
Study Registration Dates
First Submitted
November 7, 2013
First Submitted That Met QC Criteria
November 7, 2013
First Posted (Estimate)
November 14, 2013
Study Record Updates
Last Update Posted (Estimate)
October 6, 2015
Last Update Submitted That Met QC Criteria
October 5, 2015
Last Verified
October 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HipVISION Pilot - 2013
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hip Fractures
-
Khoo Teck Puat HospitalMinistry of Health, SingaporeActive, not recruitingHip Fracture Surgeries | Post-operative Hip Fractures RecoverySingapore
-
Smith & Nephew, Inc.Terminated
-
Medical Centre LeeuwardenNot yet recruitingHip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures)Netherlands
-
San Giovanni di Dio HospitalRecruitingHip Surgery | Hip ArthroplastyItaly
-
Gaziantep City HospitalCompletedFemoral Neck Fractures | Hip SurgeryTurkey (Türkiye)
-
Carilion ClinicCompleted
-
Sheffield Teaching Hospitals NHS Foundation TrustRecruitingHip FractureUnited Kingdom
-
JointResearchRecruitingHip Fractures (ICD-10 72.01-72.2)Netherlands
-
Oslo University HospitalDiakonhjemmet HospitalCompletedHip Fractures | Trochanteric Fractures | Intertrochanteric FracturesNorway
-
Tel-Aviv Sourasky Medical CenterUnknownIntertrochanteric Fractures of the HipIsrael